The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours
Authors:
- Geoffrey A. DonnanGDGeoffrey A. Donnan
- Stephen M. DavisSDStephen M. Davis
- Furlan AFAFurlan A
- Köhrmann MKMKöhrmann M
- Schwab SSSSchwab S
- Magdy H. SelimMSMagdy H. Selim
- Carlos A. MolinaCMCarlos A. Molina
- Lawrence R. WechslerLWLawrence R. Wechsler
- Maarten G. LansbergMLMaarten G. Lansberg
- Erich BluhmkiEBErich Bluhmki
- Vincent N. ThijsVTVincent N. Thijs
- Patrick D. LydenPLPatrick D. Lyden
- 1 April 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 40 (4) , 1545
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine, 2008
- StrokeThe Lancet, 2008
- Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialThe Lancet Neurology, 2008
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999